Vaxil Bio Ltd. (TSXV:VXL)
Canada flag Canada · Delayed Price · Currency is CAD
0.1600
0.00 (0.00%)
At close: Aug 18, 2026

Vaxil Bio Balance Sheet

Millions CAD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0.530.670.450.941.512.24
Cash & Short-Term Investments
0.530.670.450.941.512.24
Cash Growth
30.77%49.78%-52.24%-37.88%-32.62%48.41%
Other Receivables
0.0800.010.020.020.04
Receivables
0.0800.270.020.020.04
Prepaid Expenses
-0.010.010.020.010.01
Total Current Assets
0.610.690.730.981.542.28
Property, Plant & Equipment
-----0
Long-Term Investments
0.690.69----
Total Assets
1.291.370.730.981.542.29

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
0.0300.010.080.390.56
Accrued Expenses
0.0100.010.010.010.03
Total Current Liabilities
0.040.010.020.090.410.59
Total Liabilities
0.040.010.020.090.410.59

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
16.1316.1316.0716.0716.0716.07
Retained Earnings
-19.12-19.01-19.54-19.36-19.1-18.52
Comprehensive Income & Other
4.254.254.184.174.174.14
Shareholders' Equity
1.261.370.720.891.141.7
Total Liabilities & Equity
1.291.370.730.981.542.29

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
0.530.670.450.941.512.24
Net Cash Growth
30.77%49.78%-52.24%-37.88%-32.62%49.30%
Net Cash Per Share
0.170.240.160.340.550.82
Filing Date Shares Outstanding
3.983.982.742.742.742.74
Total Common Shares Outstanding
3.983.982.742.742.742.74
Working Capital
0.570.680.720.891.141.7
Book Value Per Share
0.320.340.260.330.410.62
Tangible Book Value
1.261.370.720.891.141.7
Tangible Book Value Per Share
0.320.340.260.330.410.62
Machinery
-----0.21